Next Article in Journal
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial
Previous Article in Journal
Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Article

Article Versions Notes

J. Clin. Med. 2020, 9(11), 3681; https://doi.org/10.3390/jcm9113681
Action Date Notes Link
article html file updated 1 September 2025 13:36 CEST Update https://www.mdpi.com/2077-0383/9/11/3681/html
article html file updated 23 July 2022 01:18 CEST Update -
article html file updated 17 November 2020 07:24 CET Original file -
article pdf uploaded. 17 November 2020 07:22 CET Updated version of record https://www.mdpi.com/2077-0383/9/11/3681/pdf
article xml uploaded. 17 November 2020 07:22 CET Update https://www.mdpi.com/2077-0383/9/11/3681/xml
article xml file uploaded 17 November 2020 07:22 CET Original file -
article pdf uploaded. 16 November 2020 16:01 CET Version of Record https://www.mdpi.com/2077-0383/9/11/3681/pdf-vor
Back to TopTop